首页> 美国政府科技报告 >Medical Research and Evaluation Facility and Studies Supporting the MedicalChemical Defense Program. A Comparison of the Biochemical Changes Produced by Vesicating and Non-Vesicating Alkylating Agents in Normal Human Epidermal Keratinocytes
【24h】

Medical Research and Evaluation Facility and Studies Supporting the MedicalChemical Defense Program. A Comparison of the Biochemical Changes Produced by Vesicating and Non-Vesicating Alkylating Agents in Normal Human Epidermal Keratinocytes

机译:医学研究和评估设施和研究支持医学化学防御计划。正常人表皮角质形成细胞中有效和非有效烷化剂产生生化变化的比较

获取原文

摘要

Task 91-23 was conducted for the U.S. Army Medical Research Institute of ChemicalDefense (USAMRICD) to compare alterations in selected biochemical endpoints using human epidermal keratinocytes (HEK) exposed in vitro to either non-vesicating (e.g., cisplatin) or vesicating (e.g., sulfur mustard; MD) alkylating agents. These data may provide insight into the biochemical mechanism(s) uniquely associated with tissue vesication. Preliminary in vivo experiments used three vesicating and three non-vesicating alkylating agents to confirm vesication potential by examining microblister formation in the hairless guinea pig (HGP). The three vesicating, alkylating agents selected were MD (positive control), mechlorethamine (nitrogen mustard; HN2), and chloroethylethyl sulfide (CEES). The three non-vesicating, alkylating agents selected were cisplatin, meiphalan, and thiotepa.

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号